Robert F. Kennedy Jr. testified before the House Committee on Appropriations and the Senate Health, Education, Labor and ...

UnitedHealth Group announced that Andrew Witty will step down as CEO due to “personal reasons.” He is being replaced by ...

President Trump’s executive order provides a framework for tying the prices of U.S. pharmaceutical products to the lower ...

The Business Group on Health is paying attention to Medicaid cuts, tariffs, threats to ERISA and more. There is no shortage ...

The Department of Justice has filed a complaint against Aetna, Elevance Health, Humana, eHealth, GoHealth, and SelectQuote, ...

Healthcare leaders are continuing to express their concerns about the changes that President Donald Trump’s administration is making to HHS. Just this week, 20 state attorneys general sued the ...

Americans are facing difficult times, including rising healthcare costs and increasing prevalence of mental health challenges. And many are looking to their employer for support. That’s why ...

Americans’ trust in the overall healthcare system is dwindling — but experts believe it can be rebuilt. Public trust in the U.S. healthcare system fell from 71.5% in 2020 to 40.1% in 2024 ...

For many healthtech innovators the real adoption challenge is not always in proving the clinical value of their product. It is overcoming structural barriers that stand in their way. So, let’s ...

Bringing a new drug to market is staggeringly inefficient: About 90% of new drugs fail in clinical trials, development times are 10-15 years, and the costs can run in excess of $2 billion dollars.

Employers should review their contracts, conduct claims analyses and more to meet their fiduciary responsibility, according to one expert.

On Friday, a San Francisco-based startup received FDA approval for the first-ever at-home cervical cancer test. The company, named Teal Health, was founded in 2020 and has raised $23 million.